Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62019TN0792

    Case T-792/19: Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)

    OJ C 10, 13.1.2020, p. 50–51 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    13.1.2020   

    EN

    Official Journal of the European Union

    C 10/50


    Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)

    (Case T-792/19)

    (2020/C 10/61)

    Language in which the application was lodged: German

    Parties

    Applicant: Agepha Pharma s. r. o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)

    Defendant: European Union Intellectual Property Office (EUIPO)

    Other party to the proceedings before the Board of Appeal: Apogepha Arzneimittel GmbH (Dresden, Germany)

    Details of the proceedings before EUIPO

    Applicant for the trade mark at issue: Applicant

    Trade mark at issue: Application for EU word mark AGEPHA — EU trade mark application No 7 007 909

    Procedure before EUIPO: Opposition proceedings

    Contested decision: Decision of the Second Board of Appeal of EUIPO of 26 August 2019 in Case R 386/2019-2

    Form of order sought

    The applicant claims that the Court should:

    vary the contested decision and reject the opposition;

    in the alternative, annul the contested decision;

    order EUIPO and the other party to pay the costs incurred in the proceedings before the Second Board of Appeal and in the present proceedings.

    Pleas in law

    infringement of Article 42(2) of Council Regulation (EC) No 207/2009;

    infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


    Top